Valuation : Enovis Corporation

Market Cap 1.11B 958M 907M 822M 1.54B 106B 1.55B 10.77B 4.14B 54.04B 4.18B 4.08B 171B P/E 2026 *
95.4x
P/E 2027 * 24.7x
Enterprise Value 2.42B 2.08B 1.97B 1.79B 3.35B 231B 3.37B 23.41B 9B 117B 9.07B 8.87B 371B EV / Sales 2026 *
1.03x
EV / Sales 2027 * 0.95x
Free-Float
98.36%
Yield 2026 *
-
Yield 2027 * -
1 day+4.73%
1 week+3.88%
Current month-21.59%
1 month-21.91%
3 months-11.56%
6 months-17.57%
Current year-27.63%
1 week 18.08
Extreme 18.08
20.22
1 month 18.08
Extreme 18.08
27.46
Current year 18.08
Extreme 18.08
31.66
1 year 18.08
Extreme 18.08
34.28
3 years 18.08
Extreme 18.08
65.03
5 years 18.08
Extreme 18.08
164.01
10 years 18.08
Extreme 18.08
164.01
Manager TitleAgeSince
Chief Executive Officer 61 12/05/2025
Director of Finance/CFO 47 01/01/2023
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 55 13/05/2008
Director/Board Member 67 21/09/2010
Chairman 64 21/05/2025
Date Insider Type Main position Quantity % Market Cap. Importance
4/9/26 Buy

Chief Administrative Officer

2,660 0.0047%
4/9/26 Buy

Chief Executive Officer

13,035 0.0228%
3/9/26 Buy

Chief Administrative Officer

5,140 0.0090%
Change 5-day change 1-year change 3-year change Capi.($)
+4.73%+3.88%-39.22%-64.70% 1.11B
+2.06%-9.10%-28.12%-6.52% 106B
-1.66%-5.22%-28.22%-5.26% 11.47B
-1.84%-5.76%+102.09%+117.75% 9.86B
-1.34%-6.25%-55.03%-72.15% 3.94B
-2.84%-6.11%-30.21%+24.24% 2.33B
+7.16%+15.73%-8.81%-66.74% 2.11B
+1.47%-5.12% - - 1.84B
-2.10%-4.52%-23.51%-30.79% 1.5B
Average +0.63%-2.24%-13.88%-13.02% 15.54B
Weighted average by Cap. +1.35%-7.80%-19.37%-0.54%

Financials

2026 *2027 *
Net sales 2.34B 2.02B 1.91B 1.73B 3.25B 224B 3.26B 22.67B 8.72B 114B 8.79B 8.59B 359B 2.45B 2.11B 2B 1.81B 3.4B 234B 3.42B 23.78B 9.14B 119B 9.22B 9.01B 377B
Net income 11.32M 9.76M 9.24M 8.37M 15.71M 1.08B 15.79M 110M 42.2M 550M 42.53M 41.6M 1.74B 39M 33.6M 31.82M 28.84M 54.1M 3.73B 54.38M 378M 145M 1.9B 146M 143M 5.99B
Net Debt 1.3B 1.12B 1.06B 964M 1.81B 125B 1.82B 12.64B 4.86B 63.39B 4.9B 4.79B 200B 1.21B 1.04B 989M 897M 1.68B 116B 1.69B 11.75B 4.52B 58.93B 4.55B 4.45B 186B
Logo Enovis Corporation
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
Employees
7,802
Date Price Change Volume
11/09/26 US$19.28 +4.73% 2,886,525
10/09/26 US$18.41 -3.26% 1,762,601
09/09/26 US$19.03 -4.75% 1,879,438
08/09/26 US$19.98 +7.65% 3,743,670
04/09/26 US$18.56 -4.33% 1,886,851
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
19.28USD
Average target price
38.33USD
Spread / Average Target
+98.82%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ENOV Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!